Related Experiment Video
Updated: Jul 18, 2026
05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Update on toxic anterior segment syndrome
Simon P Holland1, Douglas W Morck, Tracy L Lee
1Department of Ophthalmology, University of British Columbia, Vancouver, British Columbia, Canada. simon_holland@telus.net
Current Opinion in Ophthalmology
|December 13, 2006
Summary
Toxic anterior segment syndrome (TASS) is a growing complication after cataract surgery. Prompt recognition and treatment are key to excellent outcomes, though severe cases may lead to glaucoma or corneal issues.
Area of Science:
- Ophthalmology
- Surgical Complications
- Anterior Segment Diseases
Background:
- Toxic anterior segment syndrome (TASS) has emerged as a frequent complication following cataract surgery.
- Over 100 North American clinics reported TASS cases in 2006, highlighting its increasing incidence.
- TASS is a recognized noninfectious inflammatory condition of the anterior segment.
Purpose of the Study:
- To review, summarize, and update the current understanding of toxic anterior segment syndrome.
- To provide insights into the causes, presentation, and management of TASS.
- To inform on the prevention and resolution strategies for TASS.
Main Methods:
- Literature review and synthesis of current knowledge on TASS.
- Analysis of reported cases and contributing factors.
- Summary of clinical presentation, diagnostic criteria, and treatment outcomes.
Main Results:
- TASS presents as anterior segment inflammation within days of cataract surgery, responding to topical steroids.
- Identified causes include endotoxin contamination and anterior chamber access of antibiotic ointments.
- Inadequate instrument sterilization and preparation are primary contributors to TASS.
- Outcomes are typically excellent with prompt treatment; however, delayed or severe cases can lead to glaucoma and corneal edema.
Conclusions:
- Toxic anterior segment syndrome is a significant complication of modern cataract surgery.
- Increased knowledge and rapid dissemination of research findings are crucial for prevention and management.
- Effective strategies are available to help prevent and resolve TASS, improving patient outcomes.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...